Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

Green Light For First OTC Naloxone In US After FDA Raises Caution Flag During Advisory Panel

Mar 30 2023

• By Malcolm Spicer

• Source: Shutterstock

Additional Topics

International United States US States FDA Approvals Prescription To OTC Switch Advertising, Marketing & Sales Business Strategies Commercial Companies Compliance Consumer Drug Approval Standards Drug Safety Ingredients Manufacturing OTC Drugs Policy Politics Regulation Retail Advisory Committees Research & Development

More from Rx-to-OTC Switch

More from Health

Twitter feed RSS feed RSS feed

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window

Copyright © 2025 Pharma Intelligence UK Limited (Citeline), a Norstella company Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered.